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oxide (NO) in conditioned media were determined. Activation of NF-
úB and Akt pathways was assessed with enzyme-linked immunosorbent
assay (ELISA). Involvement of CD44 in HBFN-f action was evaluated using
anti-CD44 antibody and high molecular weight hyaluronan (HA).
Results: In chondrocyte monolayer cultures, HBFN-f stimulated NO
production in association with up-regulation of NF-úB and Akt. Inhibition
studies using BAY11–7085 conﬁrmed that NO production by HBFN-f
was dependent on NF-úB pathway. Inhibition studies using LY294002
revealed the requirement of PI3K/Akt pathway for NF-úB activation by
HBFN-f. Anti-CD44 treatment with anti-CD44 antibody and HA resulted
in signiﬁcant inhibition of HBFN-f actions on activation of Akt and NF-úB,
and on NO production.
Conclusions: This is the ﬁrst study demonstrating that HBFN-f activates
PI3K/Akt pathway leading to up-regulation of NF-úB through interaction
with CD44. Elucidation of intracellular pathways activated by ﬁbronectin
fragments may be helpful to understand the pathological process in OA
cartilage destruction.
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Purpose: The extracellular matrix protein, F-spondin is a marker of both
hypertrophic and osteoarthritic cartilage. Understanding the mechanisms
that regulate its expression could therefore identify key pathways that
regulate chondrocyte activity in development and disease. In this study
we investigated transcriptional regulation of human F-spondin via the
cloning and characterization of its 5′ regulatory (promoter) region.
Methods: Genomic sequence containing the 5′ regulatory region of
F-spondin was obtained by PCR of human total genomic DNA (Clontech)
using upstream primers designed from F-spondin genomic sequence
available at the gene database www.ncbi.nlm.nih.gov, gene ID: 10418.
PCR fragments were cloned into TA cloning vectors (Invitrogen) for
sequencing and subcloned into pGL3 Luciferase Reporter Vectors
(Promega) for functional analysis. Luciferase assays were performed 36
h after transfection in the human chondrosarcoma cell line, SW1353.
Results: An upstream 2.4 kb genomic sequence of human F-spondin was
obtained by PCR, subcloned and sequenced bidirectionally. DNA sequence
ﬁdelity was conﬁrmed using the NCBI blast alignment search tool. DNA
sequence analysis revealed the presence of TATA box at position −74 and
identiﬁcation of transcription factor binding sites was performed using
the JASPAR CORE database (http://jaspar.genereg.net/). High scoring
putative binding sites within the 2.4 kb promoter region included NURR1
(NR4A2-nuclear receptor), NFAT, SOX-10 and CREB1. Functional promoter
activity was assessed by transient transfection of pGL3 luciferase vectors
encoding 2.4 kb (pFS-2.4Luc) and 0.5 kb (pFS-0.5Luc) of F-spondin
upstream genomic sequence. In human chondrocytes, both pFS-2.4Luc
and pFS-0.5Luc signiﬁcantly increased luciferase activity above a pGL3
promoterless control vector, 20- and 70-fold, respectively. Since we
have previously observed that F-spondin mRNA levels are induced by
FGF-2 and PGE2 in OA chondrocytes, we examined their effects on
promoter activity. PGE-2 (10 uM) stimulated F-spondin luciferase activity
10–20-fold for both 2.4 and 0.5 kb promoter constructs (p< 0.001)
above unstimulated controls. Cotransfection of a cDNA encoding NURR1,
a transcription factor induced by PGE2 in human chondrocytes, also
increased luciferase activity (100-fold) irrespective of promoter length.
This is consistent with the presence of multiple putative NURR1 binding
sites (~16) throughout the 2.5 kb promoter region. Conversely, FGF-2
(25ng/ml) signiﬁcantly increased luciferase activity of pFS-0.5Luc (2-
fold; p < 0.05) but not pFS-2.4Luc. This ﬁnding suggests that regulation
of F-spondin via FGF-2 occurs via regulatory regions within its proximal
0.5 kb region.
Conclusions: Our results indicate that both developmental (FGF-2)
and proinﬂammatory (PGE2) factors induce F-spondin expression in
chondrocytes via discrete regions in its promoter. Sequence analysis and
transfection studies suggest that NURR1 may mediate PGE2 induction
of F-spondin via multiple binding sites in the promoter region. The
current ﬁndings are consistent with previous observations demonstrating
overlapping pro-inﬂammatory/catabolic effects of PGE2, NURR1 and
F-spondin in OA chondrocytes.
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EXPRESSION OF HUMAN ENDOGENOUS RETROVIRUS HERV-K18 IN
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Purpose: To evaluate the possible involvement of HERV-K18 in OA,
through the analysis of the expression levels of this endogenous
retrovirus in OA patients in comparison with healthy controls, and
through the analysis of different qualitative and quantitative clinical
variables.
Methods: 113 OA patients and 62 controls were included in the
study. To analyze HERV-K18 mRNA expression, quantitative RT-PCR
was performed; the transcriptional expression was expressed in a
relative manner as a normalization ratio (NR), and for controls were
assigned a NR=1. The WOMAC (Western Ontario and McMasters
Universities Osteoarthritis Index), Lequesne Index, and the Stanford
Health Assessment Questionnaire (HAQ) were analyzed in relation to
the expression levels of HERV-K18.
Results: In our study, 54 of 113 OA patients (47.8%) and 22 of 62 controls
(35.5%) showed detectable expression levels of HERV-K18. We found
statistical signiﬁcant differences when we compared the results of the
Womac Index, Lequesne Index for knee and hip, and HAQ between
OA patients with higher expression (NR > 10) vs. OA patients without
HERV-K18 expression (p =0.0003, p = 0.0005, p = 0.002, and p=0.05,
respectively), and also when the comparison was made between OA
patients with higher expression (NR > 10) vs. OA patients with low
expression of HERV-K18 (NR=1) for the Womac Index, and Lequesne
Index for knee and hip (p = 0.002, p = 0.013, and p=0.006, respectively).
Conclusions: It seems to be a relation between the health status
measurement systems and severity index for OA with the levels of
expression of HERV-K18. These results suggest a possible involvement of
HERV-K18 in the etiopathogenesis of the disease.
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THE a5 and aV INTEGRINS ARE REGULATED DURING CHONDROCYTE
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Purpose: In this study we proposed that b1 integrins family regulate
chondrocyte differentiation in the articular cartilage, as well as in the
scar and blood vessels formation during OA. This is suggested on the basis
of the integrins pattern expression on different stages of osteoarthritis in
a experimental OA rat model.The effect of GDF-5 (growth differentiation
factor 5) and BMP-7 (bone morphogenetic protein) on chondrocytes
differentiation is also analyzed here.
Methods: The experimental OA animal model, rats were subject to partial
meniscectomy on the right knee and they exercised daily to induce OA.
After the 5, 10 and 20 days, the knees were dissected and ﬁxed in 4%
PFA overnight. Then, tissues were dehydrated and parafﬁn-embedded
for preparing histological sections. Expression pattern of Integrin a5
and aV, Gdf-5, Bmp-7, and chondrocyte differentiation markers were
determinate by Immunohistochemistry and In situ hybridization. In vitro
assay for chondrogenesis were made by micromasses cultures, the cells
formed cartilaginous nodules and the effect of GDF-5 and BMP-7 on
micromasses was then tested. By immunohistochemistry were determine
the expression of different integrins subunits and MEC molecules typical
of articular cartilage. Assay for endochondral ossiﬁcation were made
by mouse knee cultures, 20 days old mice were used. The knees were
longitudinally dissected and placed on air liquid inter-phase using BGJb
medium with 0.1% bovine serum albumin. Organ cultures then were
kept for 4 days at 37°C in a 5% CO2 incubator. Hedgehog signaling was
blockade with 10 nM Cyclopamine.
